Advancements in Circulating Tumor Cell Research: Bridging Biology and Clinical Applications

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2024 Mar 28

PMID 38539545

Authors

Philip Salu

Katie M Reindl

Affiliations

Soon will be listed here.

Abstract

Circulating tumor cells (CTCs) are cells released from the primary and metastatic tumor and intravasate into the blood or lymphatic vessels, where they are transported to distant sites and act as seeds that initiate cancer metastases or the development of further lesions. Recent advances in CTC research have shown their relevance as prognostic markers for early and metastatic disease detection, predictive biomarkers for relapse, and response to medical intervention or therapy. The rapidly evolving landscape of CTC biology has opened new avenues for understanding cancer progression, metastasis, and treatment response. Additionally, translating these findings into clinical applications holds promise for improving cancer diagnostics, prognosis, and personalized therapeutic strategies. This review discusses the significance of CTCs in cancer research and their associated challenges. We explore recent developments in the detection and characterization of CTCs and their implications in cancer research and clinical practice.

Citing Articles

Liquid biopsy in cancer current: status, challenges and future prospects.

Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J Signal Transduct Target Ther. 2024; 9(1):336.

PMID: 39617822 PMC: 11609310. DOI: 10.1038/s41392-024-02021-w.

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.

Liu S, Zhang X, Wang W, Li X, Sun X, Zhao Y Mol Cancer. 2024; 23(1):261.

PMID: 39574178 PMC: 11580516. DOI: 10.1186/s12943-024-02165-x.

Detection, significance and potential utility of circulating tumor cells in clinical practice in breast cancer (Review).

Rusnakova D, Aziri R, Dubovan P, Jurik M, Mego M, Pindak D Oncol Lett. 2024; 29(1):10.

PMID: 39492933 PMC: 11526295. DOI: 10.3892/ol.2024.14756.

References

Payne K, Brooks J, Batis N, Khan N, El-Asrag M, Nankivell P . Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping. Br J Cancer. 2023; 129(10):1590-1598. PMC: 10645808. DOI: 10.1038/s41416-023-02428-2. View

Neophytou C, Kyriakou T, Papageorgis P . Mechanisms of Metastatic Tumor Dormancy and Implications for Cancer Therapy. Int J Mol Sci. 2019; 20(24). PMC: 6940943. DOI: 10.3390/ijms20246158. View

Aceto N, Bardia A, Miyamoto D, Donaldson M, Wittner B, Spencer J . Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014; 158(5):1110-1122. PMC: 4149753. DOI: 10.1016/j.cell.2014.07.013. View

Asante D, Mohan G, Acheampong E, Ziman M, Calapre L, Meniawy T . Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients. Sci Rep. 2023; 13(1):2552. PMC: 9925814. DOI: 10.1038/s41598-023-29416-z. View

Vu-Dinh H, Do Quang L, Chang C, Nhu C, Thanh H, Bui T . Immunomagnetic separation in a novel cavity-added serpentine microchannel structure for the selective isolation of lung adenocarcinoma cells. Biomed Microdevices. 2021; 23(4):51. DOI: 10.1007/s10544-021-00589-6. View

Polzer B, Medoro G, Pasch S, Fontana F, Zorzino L, Pestka A . Molecular profiling of single circulating tumor cells with diagnostic intention. EMBO Mol Med. 2014; 6(11):1371-86. PMC: 4237466. DOI: 10.15252/emmm.201404033. View

Sharma S, Zhuang R, Long M, Pavlovic M, Kang Y, Ilyas A . Circulating tumor cell isolation, culture, and downstream molecular analysis. Biotechnol Adv. 2018; 36(4):1063-1078. PMC: 5971144. DOI: 10.1016/j.biotechadv.2018.03.007. View

Kapeleris J, Kulasinghe A, Warkiani M, OLeary C, Vela I, Leo P . culture of circulating tumour cells derived from non-small cell lung cancer. Transl Lung Cancer Res. 2020; 9(5):1795-1809. PMC: 7653113. DOI: 10.21037/tlcr-20-521. View

Kuo C, Chueh D, Chen P . Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots. J Nanobiotechnology. 2019; 17(1):26. PMC: 6364392. DOI: 10.1186/s12951-019-0453-7. View

10.

Ortiz-Otero N, Marshall J, Lash B, King M . Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020; 20(1):873. PMC: 7488506. DOI: 10.1186/s12885-020-07376-1. View

11.

Yoshino T, Tanaka T, Nakamura S, Negishi R, Hosokawa M, Matsunaga T . Manipulation of a Single Circulating Tumor Cell Using Visualization of Hydrogel Encapsulation toward Single-Cell Whole-Genome Amplification. Anal Chem. 2016; 88(14):7230-7. DOI: 10.1021/acs.analchem.6b01475. View

12.

Carmona-Ule N, Gonzalez-Conde M, Abuin C, Cueva J, Palacios P, Lopez-Lopez R . Short-Term Ex Vivo Culture of CTCs from Advance Breast Cancer Patients: Clinical Implications. Cancers (Basel). 2021; 13(11). PMC: 8198105. DOI: 10.3390/cancers13112668. View

13.

El-Heliebi A, Hille C, Laxman N, Svedlund J, Haudum C, Ercan E . In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and Point Mutations in Circulating Tumor Cells. Clin Chem. 2018; 64(3):536-546. DOI: 10.1373/clinchem.2017.281295. View

14.

Lu R, Chen Q, Liu X, Shen S, Pan Z, Shi C . Detection of circulating stage III-IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology. Transl Cancer Res. 2022; 8(4):1342-1350. PMC: 8798136. DOI: 10.21037/tcr.2019.07.32. View

15.

Lu S, Tsai W, Chang Y, Chou T, Pang S, Lin P . Identifying cancer origin using circulating tumor cells. Cancer Biol Ther. 2016; 17(4):430-8. PMC: 4910938. DOI: 10.1080/15384047.2016.1141839. View

16.

Stevens M, Oomens L, Broekmaat J, Weersink J, Abali F, Swennenhuis J . VyCAP's puncher technology for single cell identification, isolation, and analysis. Cytometry A. 2018; 93(12):1255-1259. DOI: 10.1002/cyto.a.23631. View

17.

Yadav A, Pandey P, Butti R, Radharani N, Roy S, Bhalara S . The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation. Front Oncol. 2018; 8:72. PMC: 5868535. DOI: 10.3389/fonc.2018.00072. View

18.

Jiang C, Niu Z, Green M, Zhao L, Raupp S, Pannecouk B . It's not 'just a tube of blood': principles of protocol development, sample collection, staffing and budget considerations for blood-based biomarkers in immunotherapy studies. J Immunother Cancer. 2021; 9(7). PMC: 8320252. DOI: 10.1136/jitc-2021-003212. View

19.

Gorges T, Stein A, Quidde J, Hauch S, Rock K, Riethdorf S . Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch® System and the AdnaTest®. PLoS One. 2016; 11(5):e0155126. PMC: 4868337. DOI: 10.1371/journal.pone.0155126. View

20.

Liu H, Triboulet M, Zia A, Vuppalapaty M, Kidess-Sigal E, Coller J . Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection. NPJ Genom Med. 2017; 2:34. PMC: 5677973. DOI: 10.1038/s41525-017-0034-3. View